Rezultati pretraživanja
  1. prije 14 sati

    *CytoSorbents: CytoSorb Used Successfully to Help Treat Grade 4 Cytokine Release Syndrome Following CAR T-Cell Immunotherapy in First Published Case Report

  2. 4. velj
  3. 3. velj
  4. 31. sij
  5. 31. sij
  6. 30. sij
  7. 30. sij

    2020-01-29 Short sale volume (not short interest) for is 52%. 58% 8% 61% 61%

  8. 30. sij
    Prikaži ovu nit
  9. 29. sij

    Intraday DOWN alert max move results: 10% 9% 6% 3% 8% 10% 12% 13%

  10. 29. sij

    - Heating up.....

  11. 29. sij

    Short on with only 1,000 shares 🔥

  12. 29. sij

    Stocks with News: - …/hepion-nash-drug-candidate-crv4… - …/sorrento-celularity-initiate-em… TOP CORONAVIRUS STOCKS TO KEEP ON WATCH , , , , , ,

  13. 29. sij

    over $6

  14. 29. sij

    on watch

  15. 29. sij

    News again

  16. CytoSorb® is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U.

  17. 28. sij

    Small names to keep on radar tomorrow Long/Short: Recent Runner Watch-list: Previous

  18. 28. sij

    Pre-market Action Plan This Morning: long 3pts, ss fail for now ss 6pts. 165p 100%+ ss 12pts, support holding ss 1pt

  19. 28. sij

    Midday Most Tweeted Micro Caps, check out Gambiste Top 10:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.